1. Jiang, Shu-Heng, He, Ping, Ma, Ming-Ze, Qin, Wen-Xin, Zhang, Zhi-Gang. 2014. PNMA1 promotes cell growth in human pancreatic ductal adenocarcinoma. In International journal of clinical and experimental pathology, 7, 3827-35. doi:. https://pubmed.ncbi.nlm.nih.gov/25120759/
2. Wood, Thomas W P, Henriques, William S, Cullen, Harrison B, Wiedenheft, Blake, Berchowitz, Luke E. 2024. The retrotransposon-derived capsid genes PNMA1 and PNMA4 maintain reproductive capacity. In Research square, , . doi:10.21203/rs.3.rs-4559920/v1. https://pubmed.ncbi.nlm.nih.gov/39041030/
3. Liu, Pengpeng, Chen, Baiyan, Gu, Yang, Liu, Quanyan. 2018. PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 108, 492-499. doi:10.1016/j.biopha.2018.09.059. https://pubmed.ncbi.nlm.nih.gov/30243081/
4. Wood, Thomas W P, Henriques, William S, Cullen, Harrison B, Wiedenheft, Blake, Berchowitz, Luke E. 2024. The retrotransposon - derived capsid genes PNMA1 and PNMA4 maintain reproductive capacity. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.05.11.592987. https://pubmed.ncbi.nlm.nih.gov/38798495/
5. Chu, Hongyu, Shan, Yuezhan, Jiang, Chengwei, Fang, Xuedong, Yang, Zhaoying. 2025. PNMA1 is a novel immune modulator and therapeutic target in hepatocellular carcinoma linked to bile acid metabolism. In Scientific reports, 15, 738. doi:10.1038/s41598-024-84368-2. https://pubmed.ncbi.nlm.nih.gov/39754028/
6. Lee, Yong Hoi, Pang, Siew Wai, Tan, Kuan Onn. 2016. PNMA2 mediates heterodimeric interactions and antagonizes chemo-sensitizing activities mediated by members of PNMA family. In Biochemical and biophysical research communications, 473, 224-229. doi:10.1016/j.bbrc.2016.03.083. https://pubmed.ncbi.nlm.nih.gov/27003254/
7. Sankar, Dakshitha, Kannan, Balachander, Jayaseelan, Vijayashree Priyadharsini, Manicka Vasagam, Jeevitha, Arumugam, Paramasivam. 2023. Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma. In Journal of oral biology and craniofacial research, 14, 1-7. doi:10.1016/j.jobcr.2023.11.003. https://pubmed.ncbi.nlm.nih.gov/38075236/